| 2019 | Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy
| 강석민, 심효섭, 오재원, 이승태 | Article |
| 2019 | Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma | 김혜련, 박성용, 심효섭, 이창영, 조병철, 홍민희 | Article |
| 2019 | Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
| 김가민, 김혜련, 라선영, 박성용, 심효섭, 윤홍인, 이진구, 정경영, 조남훈, 조병철 | Article |
| 2019 | Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis | 김승민, 김승우, 신하영, 심효섭, 최영철 | Article |
| 2019 | Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases | 강석구, 김세훈, 심효섭, 장종희 | Article |
| 2019 | Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung | 김경아, 심효섭 | Article |
| 2019 | Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy | 김혜련, 박성용, 심효섭, 이창영, 정인경, 조병철, 차윤진, 최은아, 홍민희 | Article |
| 2019 | Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer | 김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이진구, 이창영, 조병철, 표경호, 홍민희 | Article |
| 2019 | Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics | 심효섭 | Article |
| 2019 | Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
| 심효섭 | Article |
| 2019 | Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
| 김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이창영, 조병철, 표경호, 홍민희 | Article |
| 2019 | Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer | 김경아, 김상우, 심효섭, 이창영, 조병철 | Article |
| 2018 | Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. | 김혜련, 심효섭, 조병철, 표경호, 홍민희 | Article |
| 2018 | Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation | 김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희 | Article |
| 2018 | Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces | 김문식, 심효섭, 이재석 | Article |
| 2018 | Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival | 심효섭, 홍민희 | Article |
| 2018 | Malignant lymphoma arising in cardiac myxoma, presenting with peripheral arterial emboli | 심효섭, 조윤아 | Article |
| 2018 | Clinicopathologic analysis of 10 cases of pulmonary colloid adenocarcinoma and prognostic implication of invasive micropapillary component | 심효섭, 차윤진 | Article |
| 2017 | Molecular Testing of Lung Cancers
| 심효섭 | Article |
| 2017 | PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors
| 심효섭, 차윤진 | Article |
| 2017 | Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
| 김혜련, 심효섭, 이진구, 이창영, 정인경, 조병철, 차윤진, 홍민희 | Article |
| 2017 | Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests
| 심효섭 | Article |
| 2017 | Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma | 김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희 | Article |
| 2017 | Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
| 김지형, 김혜련, 박형순, 심효섭, 이진구, 이창영, 조병철, 차윤진, 허수진, 홍민희 | Article |
| 2017 | The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
| 김은경, 심효섭, 이창영 | Article |
| 2017 | Biology of invasive mucinous adenocarcinoma of the lung.
| 심효섭, 차윤진 | Article |
| 2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | 김주항, 김혜련, 심효섭, 임선민, 조병철 | Article |
| 2017 | Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer | 김혜련, 심효섭, 조병철, 차윤진 | Article |
| 2016 | Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. | 김혜련, 심효섭, 이창영, 조병철, 차윤진 | Article |
| 2016 | MET Exon 14 Skipping in Non-Small Cell Lung Cancer. | 심효섭 | Article |
| 2016 | Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
| 김영진, 김주항, 문용화, 서영주, 심효섭, 이혜정, 임동진, 조응혁, 최병욱, 허진, 홍유진 | Article |
| 2016 | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 심효섭, 임선민, 정민규, 조병철, 최종락 | Article |
| 2016 | Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
| 김혜련, 심효섭, 차윤진 | Article |
| 2016 | Clinical course of stage IV invasive mucinous adenocarcinoma of the lung | 김혜련, 심효섭, 이혜정, 조병철 | Article |
| 2016 | Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation | 심효섭, 이은정, 이창걸, 조재호, 최병욱, 홍진우 | Article |
| 2016 | Transforming growth factor-beta 1 in humidifier disinfectant-associated children's interstitial lung disease | 김경원, 김규언, 김명준, 김상겸, 김세훈, 김윤희, 손명현, 심효섭, 이미정, 이창영 | Article |
| 2016 | Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer. | 김영진, 서영주, 심효섭, 이재석, 이혜정, 임동진, 조응혁, 최병욱, 허진, 홍유진 | Article |
| 2016 | A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib | 김혜련, 심효섭, 이혜정, 조병철, 차윤진 | Article |
| 2016 | Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
| 김은영, 김혜련, 백순명, 심효섭, 임선민, 임승택, 조병철 | Article |
| 2016 | A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer | 김혜련, 심효섭, 임선민, 정인경, 조병철, 허수진 | Article |
| 2016 | An unusual cause of early aortic bioprosthetic valve failure | 송신정, 심지영, 심효섭, 장병철, 홍그루 | Article |
| 2015 | Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
| 김대준, 김영삼, 신주혜, 심효섭, 이진구, 이창영, 정경영 | Article |
| 2015 | Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
| 김대준, 심효섭, 이진구, 이창영, 정경영 | Article |
| 2015 | LAMC2 enhances the metastatic potential of lung adenocarcinoma | 김주항, 문용화, 심효섭, 정현철 | Article |
| 2015 | Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung | 심효섭, 차윤진 | Article |
| 2015 | The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer | 김대준, 김세규, 김은영, 김주항, 김혜련, 김효송, 박지수, 심효섭, 이창영, 장준, 정인경, 정지예, 조병철 | Article |
| 2014 | Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
| 심효섭 | Article |
| 2014 | A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer | 심효섭, 임선민, 조병철 | Article |
| 2014 | Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma | 김대준, 김민환, 김은영, 김주항, 김현정, 김혜련, 박지수, 배미경, 심효섭, 이진구, 이창영, 임선민, 정경영, 정지예, 조병철 | Article |
| 2014 | Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma | 김대준, 김세규, 김주항, 김혜련, 심효섭, 임선민, 장준, 조병철 | Article |
http://orcid.org/0000-0002-5718-3624
(Yonsei Health Research Network)
(8701798400)
